Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8618448 | Journal of Cardiothoracic and Vascular Anesthesia | 2018 | 8 Pages |
Abstract
The performance of the Schnider pharmacokinetic model for TCI propofol was poor, with a tendency toward under-prediction of blood propofol concentration, especially at higher average concentrations of propofol. While mitigating the risk of awareness, the risk of other adverse effects like hypotension and cardiorespiratory depression is increased. Patients should therefore be adequately monitored, and predicted plasma propofol concentrations taken in context with other patient parameters. A lower target concentration of propofol is probably sufficient to maintain an adequate depth of anesthesia as measured by BIS.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Aaron Kwang Yang Lee, Aaron Yik Hang Kong, Chee Fai Kong,